Study published in EClinicalMedicine confirms safety and immunogenity of world’s first Needle-free COVID-19 DNA vaccine
Immunization coverage is critical to eradicating potentially deadly diseases while reducing the burden of disease. Safe, cost-effective, and patient-friendly injectable drug delivery systems play a crucial role in the success of global vaccination programs. PharmaJet leverages innovative jet injection technology to offer a needle-free, accurate, and more comfortable method of vaccine delivery. With unparalleled ease-of-use and revolutionary technology that ensures proper dosing, the company can deliver more potency than a needle and syringe with less vaccine positioning it to become the new standard of care. With its versatility, safety, and exceptional client value, PharmaJet earns Frost & Sullivan’s 2018 Technology Innovation Award in the global drug delivery systems market.
Related posts
